Potential pitfalls of reproductive direct-to-consumer testing
The availability of direct-to-consumer (DTC) testing has dramatically increased over the past 2 decades, particularly those targeted at reproduction and fertility. Several ethical concerns exist with regard to DTC tests, including the lack of governmental regulation and consumer protection, standard...
Main Authors: | Frank Z. Stanczyk, Ph.D., Rachel S. Mandelbaum, M.D., Rogerio A. Lobo, M.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | F&S Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666334122000083 |
Similar Items
-
Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting
by: Barbara Buonomo, et al.
Published: (2021-09-01) -
Updating the landscape of direct-to-consumer pharmacogenomic testing
by: Filipski KK, et al.
Published: (2017-08-01) -
Individualization of FSH Doses in Assisted Reproduction: Facts and Fiction
by: Frank J. Broekmans
Published: (2019-04-01) -
Direct-to-consumer genetic testing
by: Jong-Won Kim
Published: (2019-09-01) -
The 10th Oxbridge varsity medical ethics debate-should we fear the rise of direct-to-consumer genetic testing?
by: Christian Michael Armstrong Holland, et al.
Published: (2018-10-01)